Company Summary: First Choice Healthcare Solutions, Inc.

Business Overview

• Primary Focus: Transitioning from an orthopedic-focused model to a national chain of primary care and wellness clinics.
• Strategic Shift: Dissolution of legacy orthopedic and physical therapy services; development of branded primary care clinics with a focus on personalized, patient-centric care.

Operations

• Headquarters: Melbourne, Florida.
• Employees: 1 full-time salaried employee and 7 contract professionals (as of December 31, 2024).
• Main subsidiaries:
  • FCID Medical, Inc. (operates first medical practice)
  • The Good Clinic Properties, LLC (leases clinic locations)
  • Leading Primary Care, Inc. (planned future holding company)
  • The Good Clinic Group, Inc. (operates primary care clinics)
  • Live Well Drugstore, Inc. (compounding pharmacy operations)
  • Pointe Medical Services, Inc., Pointe Med Pharmacy, Inc., Livewell MD, Inc., and Livewell Drugstore, Inc. (recent acquisitions)

Core Business Activities

Primary Care & Wellness Clinics

• Services Provided:

  • Preventive care: physical exams, vaccinations, screenings
  • Acute illness diagnosis and treatment
  • Chronic disease management (diabetes, hypertension, COPD, etc.)
  • Women’s health: Pap smears, family planning, prenatal/postpartum
  • Men’s health: Prostate, testicular exams, ED screening
  • Mental health: depression, anxiety, stress counseling
  • Pediatric: well-child visits, immunizations
  • Geriatric: health assessments, fall risk management
  • Care coordination and referrals
  • Health education

• Focus on Nurse Practitioners: Nearly all clinics staffed predominantly by Nurse Practitioners, which provides about a 25% labor cost advantage over traditional physician staff.

Supporting Services and Infrastructure

• Medical Laboratory & Diagnostics
• Internal Compounding Pharmacy (Live Well Drugstore)
• Quality of Life & Anti-Aging Services:
  • Hormone Replacement Therapy (HRT, TRT)
  • Medically assisted weight management
  • Regenerative medicine (stem cell, PRP, exosome therapy)
  • Biohacking programs (wearable devices, supplements, personalized coaching)
• Technology:
  • Cloud-based Electronic Medical Records (EMR) system complying with federal standards
  • Telehealth services

Pharmacy & Compound Medications

• Live Well Drugstore:
  • Operates in Florida, Georgia, Mississippi
  • Plans to attain FDA 503B registration to expand offerings
  • To supply personalized, compounded medications (hormones, pain meds, cancer drugs, IV therapies)
  • Will potentially expand to include sterile (503B) and non-sterile (503A) compounded drugs
  • Focus on lower-cost, personalized medications collaboratively with healthcare providers

Market & Strategy

• Market Size & Growth:

  • U.S. healthcare spending: $4.5 trillion in 2022 (~17.3% of GDP)
  • Primary care market: estimated at $271 billion in 2023, expected to grow at 3.36% CAGR through 2030
  • Emphasis on expanding primary care access to reduce overall healthcare costs and improve outcomes
  • Key competitors include virtual providers (Hims, Ro), brick-and-mortar clinics (Revibe, Oak Street, One Medical), private practices

• Growth Plan:

  • Open multiple clinics across high-growth markets, focusing initially on Florida, Minnesota, Denver, and Phoenix
  • Use acquisitions (e.g., Pointe Medical, The Good Clinic) to expand offerings and geographic footprint
  • Target a total of 30 new clinics over four years
  • Leverage centralized management and back-office services for efficiency

Financial & Operational Highlights

• Revenue & Income:
  • 2024: No revenue reported (discontinued services); net loss of approximately $3.94 million; operating loss of about $1.29 million
  • 2023: Revenue of approximately $30,000; net loss of about $8.26 million
• Employees: 1 full-time employee + 7 contractors
• Customer Base: Not explicitly specified; ongoing expansion aims to grow patient population in targeted markets
• Current Stock Price: As of March 25, 2025, approximately $0.0078 per share

Additional Notes

• Legal & Financial Events:
  • Filed for bankruptcy in June 2020; emerged in April 2022
  • Acquired multiple related healthcare businesses post-bankruptcy
  • Has issued and manages various convertible and preferred stocks
• Intended Future Actions:
  • Completion of an IPO aiming to raise $10 million
  • Uplisting to NYSE upon successful capital raise
• Financial Status:
  • Significant accumulated deficit (~$68.17 million as of December 31, 2024)
  • Minimal current cash (~$19,915)
  • Has relied heavily on debt and convertible notes for financing

Summary: First Choice Healthcare Solutions, Inc. is transitioning from an orthopedic and physical therapy provider to a comprehensive primary care and wellness network. It develops clinics staffed mainly by Nurse Practitioners, integrated with ancillary services such as labs and pharmacies, to offer personalized, high-quality care. The company is actively acquiring primary care practices and pharmacies, expanding its geographic footprint, and developing new service offerings focused on preventive health, regenerative medicine, hormonal therapy, and biohacking. Financially, it remains in early-stage, with net losses, negligible revenue in recent periods, and significant debt.